Skip to content

Big White Wall Live Therapy RCT

Randomised controlled trial evaluating cognitive behavioural therapy delivered on an internet platform by Big White Wall

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13496713
Enrollment
100
Registered
2014-12-10
Start date
2014-11-17
Completion date
Unknown
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health Mental and Behavioural Disorders

Interventions

Participants are randomly allocated to receive one of two interventions: 1. CBT-FtF - CBT-FtF is face to face CBT that participants will receive, in an IAPT service, from a qualified CBT therapist. Pa

Sponsors

North East London NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. English-speaking adults (aged 18 years or over) entering participating IAPT services via self-referral or GP referral 2. People who have been offered CBT at IAPT step 3 for symptoms associated with depression or a specific anxiety disorder (generalised anxiety disorder, panic disorder, social anxiety disorder)

Exclusion criteria

Exclusion criteria: 1. Non-English speaking people 2. People with cognitive impairment 3. People currently receiving additional psychological treatment 4. People with drug and/or alcohol dependence 5. People with a diagnosis of a psychotic or bipolar disorder 6. People with a diagnosis of post-traumatic stress disorder or obsessive compulsive disorder 7. Individuals who have asked not to be approached for research

Design outcomes

Primary

MeasureTime frame
The study includes participants with depression and anxiety disorders, and there are three primary outcome measures: 1. To assess depression: Patient Health Questionnaire (PHQ9) 2. To assess anxiety: Generalised Anxiety Disorder 7item scale (GAD7) 3. To assess functioning: The Work and Social Adjustment Scale (WSAS) These measures will be compared across groups at baseline, treatment end (12 weeks) and 6 month follow up. We will also measure client satisfaction with treatment (CSQ-8) at treatment end (12 weeks) and 6 month follow up.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026